AA
AlphaCentric Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-675,000
| Closed | -$4.17M | – | 232 |
|
|
2024
Q2 | $4.17M | Hold |
675,000
| – | – | 3.07% | 2 |
|
|
2024
Q1 | $3.43M | Hold |
675,000
| – | – | 2.07% | 6 |
|
|
2023
Q4 | $4.04M | Buy |
675,000
+26,000
| +4% | +$156K | 2.71% | 3 |
|
|
2023
Q3 | $4.59M | Buy |
649,000
+79,000
| +14% | +$559K | 2.61% | 3 |
|
|
2023
Q2 | $4.01M | Buy |
570,000
+150,500
| +36% | +$1.06M | 2.23% | 5 |
|
|
2023
Q1 | $3.5M | Buy |
419,500
+294,500
| +236% | +$2.46M | 2.41% | 4 |
|
|
2022
Q4 | $1.44M | Buy |
125,000
+55,000
| +79% | +$631K | 1.42% | 15 |
|
|
2022
Q3 | $882K | Buy |
+70,000
| New | +$882K | 0.91% | 32 |
|
|
2021
Q4 | $242K | Buy |
+17,500
| New | +$242K | 0.07% | 91 |
|